213 related articles for article (PubMed ID: 28476518)
41. Left main percutaneous coronary intervention in ACS or stable coronary artery disease: acute and long-term results.
Varani E; Vecchio S; Aquilina M; Vecchi G; Balducelli M; Frassineti V; Margheri M
Minerva Cardioangiol; 2016 Feb; 64(1):23-33. PubMed ID: 26989947
[TBL] [Abstract][Full Text] [Related]
42. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
[TBL] [Abstract][Full Text] [Related]
43. Patients with non-ST-elevation myocardial infarction and without chest pain are treated less aggressively and experience higher in-hospital mortality.
Zdzienicka J; Siudak Z; Zawiślak B; Dziewierz A; Rakowski T; Dubiel J; Dudek D
Kardiol Pol; 2007 Jul; 65(7):769-75; discussion 776-7. PubMed ID: 17694458
[TBL] [Abstract][Full Text] [Related]
44. Admission with metabolic disorder is a useful predictor of the 1-year prognosis for patients with unstable angina, but not for patients with acute myocardial infarction: east-Osaka acute coronary syndrome registry.
Hoshida S; Teragaki M; Lim YJ; Mishima M; Nakajima O; Kijima Y; Yoshimaru K; Tsuchihashi M; Morita Y; Iwasaka T;
Coron Artery Dis; 2011; 22(6):416-20. PubMed ID: 21555939
[TBL] [Abstract][Full Text] [Related]
45. Pro-oxidant HDL predicts poor outcome in patients with ST-elevation acute coronary syndrome.
Distelmaier K; Schrutka L; Seidl V; Winter M; Wurm R; Mangold A; Perkmann T; Maurer G; Adlbrecht C; Lang IM
Thromb Haemost; 2015 Jul; 114(1):133-8. PubMed ID: 25831998
[TBL] [Abstract][Full Text] [Related]
46. HDL-cholesterol level provides additional prognosis in acute coronary syndromes.
Correia LC; Rocha MS; Esteves JP
Int J Cardiol; 2009 Aug; 136(3):307-14. PubMed ID: 18706714
[TBL] [Abstract][Full Text] [Related]
47. Management of acute coronary syndromes in a developing country; time for a paradigm shift? an observational study.
Medagama A; Bandara R; De Silva C; Galgomuwa MP
BMC Cardiovasc Disord; 2015 Oct; 15():133. PubMed ID: 26497226
[TBL] [Abstract][Full Text] [Related]
48. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome.
Kaski JC; Consuegra-Sanchez L; Fernandez-Berges DJ; Cruz-Fernandez JM; Garcia-Moll X; Marrugat J; Mostaza J; Toro-Cebada R; González-Juanatey JR; Guzmán-Martínez G;
Atherosclerosis; 2008 Nov; 201(1):176-83. PubMed ID: 18336825
[TBL] [Abstract][Full Text] [Related]
49. Association between admission lactate levels and mortality in patients with acute coronary syndrome: a retrospective cohort study.
Liang D; Zhou X; Hong X; Feng X; Shan P; Xie Q; Xu T; Cai M; Zhou J; Wang S; Huang W
Coron Artery Dis; 2019 Jan; 30(1):26-32. PubMed ID: 30398983
[TBL] [Abstract][Full Text] [Related]
50. Prognostic Significance of Uric Acid Levels in Ischemic Stroke Patients.
Zhang X; Huang ZC; Lu TS; You SJ; Cao YJ; Liu CF
Neurotox Res; 2016 Jan; 29(1):10-20. PubMed ID: 26376636
[TBL] [Abstract][Full Text] [Related]
51. [Hemoglobin: simply a laboratory value or a powerful predictor of risk in patients with acute coronary syndrome?].
Ferreira M; António N; Gonçalves F; Monteiro P; Gonçalves L; Freitas M; Providência LA
Rev Port Cardiol; 2012 Feb; 31(2):121-31. PubMed ID: 22244550
[TBL] [Abstract][Full Text] [Related]
52. A Low Early High-density Lipoprotein Cholesterol Level Is an Independent Predictor of In-hospital Death in Patients with Acute Coronary Syndrome.
Ishida M; Itoh T; Nakajima S; Ishikawa Y; Shimoda Y; Kimura T; Fusazaki T; Morino Y
Intern Med; 2019 Feb; 58(3):337-343. PubMed ID: 30210100
[TBL] [Abstract][Full Text] [Related]
53. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
[TBL] [Abstract][Full Text] [Related]
54. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
[TBL] [Abstract][Full Text] [Related]
55. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
[TBL] [Abstract][Full Text] [Related]
56. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI.
Akpek M; Kaya MG; Uyarel H; Yarlioglues M; Kalay N; Gunebakmaz O; Dogdu O; Ardic I; Elcik D; Sahin O; Oguzhan A; Ergin A; Gibson CM
Atherosclerosis; 2011 Nov; 219(1):334-41. PubMed ID: 21831375
[TBL] [Abstract][Full Text] [Related]
57. Thai Registry in Acute Coronary Syndrome (TRACS)--an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year.
Srimahachota S; Boonyaratavej S; Kanjanavanit R; Sritara P; Krittayaphong R; Kunjara-Na-ayudhya R; Tatsanavivat P;
J Med Assoc Thai; 2012 Apr; 95(4):508-18. PubMed ID: 22612004
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of admission fasting glucose levels in patients with acute coronary syndrome.
Kolman L; Hu YC; Montgomery DG; Gordon K; Eagle KA; Jackson EA
Am J Cardiol; 2009 Aug; 104(4):470-4. PubMed ID: 19660596
[TBL] [Abstract][Full Text] [Related]
59. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
[TBL] [Abstract][Full Text] [Related]
60. Uric acid, allopurinol therapy, and mortality in patients with acute heart failure--results of the Acute HEart FAilure Database registry.
Málek F; Ošťádal P; Pařenica J; Jarkovský J; Vítovec J; Widimský P; Linhart A; Fedorco M; Coufal Z; Miklík R; Krűger A; Vondraková D; Špinar J
J Crit Care; 2012 Dec; 27(6):737.e11-24. PubMed ID: 22699032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
